MIRA INFORM REPORT

 

 

Report Date :

20.12.2008

 

IDENTIFICATION DETAILS

 

Name :

PRATI, DONADUZZI & CIA LTDA.

 

 

Registered Office :

Rua Mitsugoro Tanaka,145 - Centro Indústrial Nilton Arruda

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

03.11.1993

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacture of Chemical Pharmaceutical Products - Medicines.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 


 

 

name of the company

 

PRATI, DONADUZZI & CIA LTDA.

 

 

ADDRESSES

 

MAIN ADDRESS:

RUA MITSUGORO TANAKA,145 - CENTRO INDÚSTRIAL NILTON ARRUDA

ZIP CODE/CITY:

85903-930 - TOLEDO/PR

 

 

PHONE:

45 3277-1166

FAX:

45 3277-0991

E-MAIL:

contabilidade@pratidonaduzzi.com.br

WEB SITE:

www.pratidonaduzzi.com.br

 

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF CHEMICAL PHARMACEUTICAL PRODUCTS - MEDICINES.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

03/11/1993

REGISTER DATE:

03/11/1993

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

73.856.593/0001-66

STATE REGISTER:

418.06327-06

 

 

SHARE CAPITAL:

R$ 12.900.000,00

LAST REGISTER OF CAPITAL:

27/11/2007

 

BOARD OF DIRECTORS:

 

 

 

CELSO AGUSTINHO PRATI

MANAGING PARTNER

LUIZ DONADUZZI

MANAGING PARTNER

ARNO DONAZUZZI

DIRECTOR

 


 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

LUIZ DONADUZZI

R$ 7.224.000,00

CELSO AGUSTINHO PRATI

R$ 3.612.000,00

ARNO DONADUZZI

R$ 2.064.000,00

 

AFFILIATES / SUBSIDIARIES:

 

 

 

CENTRAL PACK EMBALAGENS LTDA

 

CENTRO DE ESTUDOS DE BIOEQUIVALENCIA VINHEDO DIST. MED. LTD

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON NOVEMBER 03, 1993 AS FARMACO INDUSTRIA FARMACEUTICA LTDA TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON NOVEMBER 11, 2002 IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

THE COMPANY OPERATES WITH THE TRADE NAME: PRATI, DONADUZZI

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 


FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2007, 31/12/2006 AND 31/12/2005.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2007

31/12/2006

31/12/2005

CASH AND BANKS

2.610.912,05

433.252,15

1.491.951,34

CLIENTS

35.986.596,42

25.435.770,59

22.228.514,64

DISCOUNTED NOTES

-1.018.858,15

 

 

NOTES RECEIVABLE

 

402.752,52

81.485,20

ADVANCES

1.826.397,80

1.762.959,07

730.845,49

ADVANCE TO EMPLOYEES

 

252.028,53

 

RECOVERABLE TAXES

1.799.757,67

3.175.846,06

2.566.089,37

CURRENT ACCOUNT

 

 

33.816,96

INVENTORY

14.823.804,15

14.970.874,97

9.810.023,75

PRE PAID EXPENSES

3.346.615,07

3.494.006,68

2.138.243,14

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

59.375.225,01

49.927.490,57

39.080.969,89

 

LONG-TERM RECEIVABLES:

 

 

 

LEASING

1.009.052,47

1.143.881,18

724.801,14

INVESTMENTS

 

 

20.590,60

JUDICIAL DEPOSITS

5.805,04

 

 

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

1.014.857,51

1.143.881,18

745.391,74

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

 

 

4.650,45

FIXED ASSETS

41.799.651,43

32.063.535,17

17.368.178,03

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

41.799.651,43

32.063.535,17

17.372.828,48

 

================

================

================

TOTAL ASSETS

102.189.733,95

83.134.906,92

57.199.190,11

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2007

31/12/2006

31/12/2005

 

 

 

 

LOANS AND FINANCING

14.173.808,03

13.239.449,53

3.442.522,51

ACCOUNTS PAYABLE

 

9.434,02

2.127,64

CURRENT ACCOUNT

 

490.493,84

5.721,83

SUPPLIERS

15.282.792,80

13.419.025,13

8.991.261,55

TAXES & CONTRIBUTIONS

6.033.815,77

1.764.735,50

2.490.489,52

LABOR OBLIGATIONS

4.437.332,68

1.793.350,21

1.273.399,27

OTHER

 

181.309,43

34.413,42

ADVANCE FROM CLIENTS

1.176.132,47

996.960,55

295.320,02

GOODS FROM THIRD PARTIES

 

 

2.142,15

PROVISIONS

 

1.911.904,31

1.335.503,80

CURRENT ACCOUNTS WITH PARTNERS

 

930.210,42

 

SOCIAL OBLIGATIONS

292.390,84

 

 

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

41.396.272,59

34.736.872,94

17.872.901,71

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

 

6.450.642,95

7.743.169,12

INSTALLMENTS TAXES PAYABLE

 

20.638.872,74

13.689.287,15

INSTALLMENTS TAXES PAYABLE

23.230.976,06

 

 

SUPPLIERS

6.689.957,56

 

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

29.920.933,62

27.089.515,69

21.432.456,27

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

12.900.000,00

8.600.000,00

8.600.000,00

ACCRUED PROFIT (LOSS)

17.972.527,74

12.708.518,29

9.293.832,13

 

----------------

----------------

----------------

TOTAL NET EQUITY

30.872.527,74

21.308.518,29

17.893.832,13

 

================

================

================

TOTAL LIABILITIES

102.189.733,95

83.134.906,92

57.199.190,11

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2007, 31/12/2006 AND 31/12/2005.

( FIGURES ARE IN REAIS ).

 

 

31/12/2007

31/12/2006

31/12/2005

 

 

 

 

GROSS SALES

154.165.042,35

130.230.364,36

97.335.694,52

(-) TAXES ON SALES

28.238.938,92

21.179.251,33

17.633.718,25

 

----------------

----------------

----------------

NET SALES

125.926.103,43

109.051.113,03

79.701.976,27

(-) COST OF SOLD GOODS

76.278.401,77

69.295.271,45

46.996.113,55

 

----------------

----------------

----------------

GROSS PROFIT

49.647.701,66

39.755.841,58

32.705.862,72

OPERATING REVENUE (EXPENSE)

-43.655.400,94

-31.022.633,67

-18.830.307,46

FINANCIAL REVENUE(EXPENSE)

-3.526.220,94

-4.434.879,96

-3.232.339,86

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

2.466.079,78

4.298.327,95

10.643.215,40

NON-OPERATING RESULT

42.513,40

21.294,87

-8.753,34

CONTRIBUTION/INCOME TAX

 

-632.237,01

-3.567.354,11

 

----------------

----------------

----------------

NET PROFIT (LOSS)

2.508.593,18

3.687.385,81

7.067.107,95

 

MONTHLY SALES

 

  2008

  2007

 

 

---------------------

---------------------

 

JANUARY

R$ 15.367.196,77

R$ 9.819.362,93

 

FEBRUARY

R$ 11.936.087,22

R$ 8.745.618,35

 

MARCH

R$ 15.020.538,02

R$ 11.460.319,20

 

APRIL

R$ 16.687.376,27

R$ 10.503.241,86

 

MAY

R$ 19.374.863,92

R$ 12.705.598,81

 

JUNE

R$ 17.590.476,17

R$ 14.734.466,30

 

JULY

R$ 18.623.659,48

R$ 14.402.814,81

 

AUGUST

R$ 17.960.782,49

R$ 14.053.718,37

 

SEPTEMBER

 

R$ 12.001.126,24

 

OCTOBER

 

R$ 13.980.397,08

 

NOVEMBER

 

R$ 3.306.243,15

 

DECEMBER

 

R$ 16.631.433,59

 

TOTAL

R$ 132.560.980,34

R$ 142.344.340,69

 

 

RATIOS:

31/12/2007

31/12/2006

31/12/2005

QUICK RATIO

1,08

 

1,01

 

1,64

 

CURRENT RATIO

1,43

 

1,44

 

2,19

 

ACCOUNTS RECEIVABLE TURNOVER

3,50

TIMES

4,29

TIMES

3,59

TIMES

DAYS' SALES IN RECEIVABLES

102,88

DAYS

83,97

DAYS

100,40

DAYS

INVENTORY TURNOVER

5,15

TIMES

4,63

TIMES

4,79

TIMES

ACCOUNTS PAYABLE PERIOD

72,13

DAYS

69,71

DAYS

68,87

DAYS

RETURN ON ASSETS

1,23

TIMES

1,31

TIMES

1,39

TIMES

SALES TURNOVER ON NET EQUITY

4,08

TIMES

5,12

TIMES

4,45

TIMES

NET WORTH TIE-UP

1,35

 

1,50

 

,97

 

INDEBTEDNESS

2,31

 

2,90

 

2,20

 

EQUITY RATIO

30,21

%

25,63

%

31,28

%

WORKING CAPITAL RATIO

43,43

%

43,73

%

118,66

%

GENERAL SOLVENCY

1,43

 

1,34

 

1,46

 

RETURN ON NET EQUITY

8,13

%

17,30

%

39,49

%

RETURN ON SALES (PROFIT MARGIN)

1,99

%

3,38

%

8,87

%

GROSS PROFIT MARGIN

39,43

%

36,46

%

41,04

%

OPERATIONAL RESULT

1,96

%

3,94

%

13,35

%

SALES TURNOVER ON LIABILITIES

3,04

TIMES

3,14

TIMES

4,46

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,35

 - OFFICIAL RATE ON 18/12/2008

US$ 1,00 = R$ 1,77

 - OFFICIAL RATE ON 31/12/2007

US$ 1,00 = R$ 2,13

 - OFFICIAL RATE ON 31/12/2006

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2005

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL STANDING. DESPITE THE HIGH LEVEL OF INDEBTEDNESS, IT IS NOTED GOOD LIQUIDITY RATIOS AND POSITIVE WORKING CAPITAL AMOUNT AS WELL AS GROWING SALES AND PROFITABILITY.

 

REAL ESTATE:

 

OWNED PREMISES ARE VALUED AT R$ 5.799.274,53

 

VEHICLES:

 

OWNED VEHICLES ARE VALUED AT R$ 2.481.656,77

MACHINES:

 

 

OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 22.499.336,46

 

INSURANCE

 

INSURANCE COMPANY:

BANCO ITAU /  BRADESCO

COVERAGE:

0

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

34029   45 3333-5506

 

BANCO BRADESCO S/A

45 3224-4534

CASCAVEL/PR

BANCO ITAU S/A

0316   45 3225-0044

 

BANCO ABN AMRO REAL S/A

 

TOLEDO/PR

BANCO NOSSA CAIXA S/A

 

CASCAVEL/PR

BANCO SAFRA S/A

 

CASCAVEL/PR

HSBC BANK BRASIL S/A

 

CASCAVEL/PR

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF CHEMICAL PHARMACEUTICAL PRODUCTS - MEDICINES.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

INDIA, MEXICO, ISRAEL, SWITZERLAND, GERMANY, SPAIN, CHINA AND UNITED STATES.

 

EXPORTS TO:

THE COMPANY DOES NOT EXPORT

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

 

AMERICAN FARMA DIST. LTDA

SÃO PAULO/SP

 

ASSECAM DIST. HOSP. LTDA

SÃO PAULO/SP

 

BH FARMA COMÉRCIO LTDA

BELO HORIZONTE/MG

 

COM. CIRURGICA RIO CLARENCE

 

 

DEPARTAMENTO ADM. DA COORD. DA SAUDE SISTEMA PENITENCIÁRIO

SÃO PAULO/SP

 

DIST. DE MEDICAMENTOS BRASIL MIRACEMA

 

 

DROGA FORTE

RECIFE/PE

 

DROGARIA SÃO PAULO S/A

SÃO PAULO/SP

 

DROGASIL S/A

SÃO PAULO/SP

 

HEALTHENICA PROD. HOSPILARES LTDA

SÃO PAULO/SP

 

HIFON DISTR. LTDA

SÃO PAULO/SP

 

MEDISIL COM. FARMA. HOSP. LTDA

 

 

PRO-DIET FARMACEUTICA LTDA

CURITIBA/PR

 

REPRESS DIST. LTDA

SÃO PAULO/SP

 

TOTAMED COM. PROD. FARM. HOSP. LTDA

SÃO PAULO/SP

 

 

STAFF:

 

THE COMPANY HAS: 2023 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1993. SO FAR IT OPERATES WITH HIGH SCALE OF ACTIVITIES, A CLEAR TRADE HISTORY AND VERY GOOD PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

AB FARMO QUIMICA

ABÁPILIS/GO

11 2161-0811

ALCOA ALUMINIO S/A

SÃO PAULO/SP

 

AVENTIS PHARMA S/A

 

 

BISFARMA INDUSTRIA DE EMBALAGENS LTDA

PEDREIRA/SP

 

CIA INDUSTRIA DE VIDROS - CIV

VITÓRIA DE STO. ANTÃO/PE

81 3523-1997

COMPANHIA INDUSTRIAL DE VIDROS CIV

 

 

LABORATÓRIOS PFIZER LTDA

GUARULHOS/SP

11 6464-7344

LOGISTICA GERAL LTDA

GUARULHOS/SP

 

M CASSAB INDUSTRIA E COMERCIO LTDA

SÃO PAULO/SP

11 5522-7788

RIPASA S/A

SÃO PAULO/SP

 

TOCAUTO CAMINHÕES LTDA

 

99 2101-3200

VALDEQUIMICA PRODUTOS QUIMICOS LTDA

 

11 3721-1077

VEDAT TAMPAS HERMELICAS LTDA

EMBÚ/SP

11 2133-1212

WILLETT LTDA

SÃO PAULO/SP

 

 

FOREIGN SUPPLIERS:

COUNTRY:

 

ALEMBIC LTDA

INDIA

 

COMWIN INTERNATIONAL LTD

SUIZA

 

DABUR INDIA

ÍNDIA

 

INLERLUDE COMPANY S/A

UNITED STATES

 

MOHS CATALANA S/A

SPAIN

 

SHIJIAHUANG PHARM

CHINA

 

SRWKA GMBH

GERMANY

 

ZHEJIANG

CHINA

 

 

PAYMENT HISTORY:

 

32 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 1.061.994,00

 

AMOUNT OF INVOICES PAID: 335

TOTAL OF PROMPT PAYMENTS: 99,9%

TOTAL OF DELAYED PAYMENTS: 0,1%

 

HIGHEST INVOICE: R$ 23.928,00

HIGHEST CREDIT: R$ 23.928,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

ALL

7

15

R$ 51.772,00

DUE WITHIN 30 DAYS

7

15

R$ 51.772,00

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR OVER 10 YEARS. UP TO DATE IT HAS A NORMAL FINANCIAL STANDING, A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOUR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

AN INITIAL CREDIT LIMIT OF USD 1.000.000,00 MAY BE CONSIDERED.

 

 

PRATI, DONADUZZI & CIA LTDA.

 

 

 

 

BALANCE SHEET ANALYSIS

FIGURES ARE IN REAIS

 

 

 

 

31-12-07

 

31-12-06

 

ASSETS

 

%

 

%

Current Assets

 $            59,375,225

58.10

 $            49,927,491

60.06

Fixed Assets

 $            41,799,651

40.90

 $            32,063,535

38.57

TOTAL ASSETS

 $          102,189,734

100.00

 $            83,134,907

100.00

LIABILITIES

 

 

 

 

Current Liabilities

 $            41,396,273

40.51

 $            34,736,873

41.78

Long-Term Liabilities

 $            29,920,934

29.28

 $            27,089,516

32.59

TOTAL LIABILITIES

 $            71,317,206

69.79

 $            61,826,389

74.37

Deferred Income

 $                            -  

0.00

 $                            -  

0.00

Net Equity

 $            30,872,528

30.21

 $            21,308,518

25.63

TOTAL LIABILITIES + NET EQUITY

 $          102,189,734

100.00

 $            83,134,907

100.00

PROFIT AND LOSS ACCOUNTS

 

 

 

 

Net Sales

 $          125,926,103

100.00

 $          109,051,113

100.00

Costs

 $            76,278,402

60.57

 $            69,295,271

63.54

Gross Profit

 $            49,647,702

39.43

 $            39,755,842

36.46

Operating expenses

 $          (43,655,401)

-34.67

 $          (31,022,634)

-28.45

operational Result

 $              2,466,080

1.96

 $              4,298,328

3.94

Net Profit (loss)

 $              2,508,593

1.99

 $              3,687,386

3.38

COMPLEMENTARY DATA

 

 

 

 

Inventory

 $            14,823,804

 

 $            14,970,875

 

Accounts receivable

 $            35,986,596

 

 $            25,435,771

 

Accounts Payable

 $            15,282,793

 

 $            13,419,025

 

Property, plant and equipment

 $            41,799,651

 

 $            32,063,535

 

Purchases

 $            41,799,651

 

 $            32,063,535

 

Financial Expenses

 $             (3,526,221)

 

 $             (4,434,880)

 

Foreign Currency Assets

 

 

 

 

Foreign Currency Liabilities

 

 

 

 

Working Capital

 $            17,978,952

 

 $            15,190,618

 

RATIOS:

 

 

 

 

QUICK RATIO

                           1.08

 

                           1.01

 

CURRENT RATIO

                           1.43

 

                           1.44

 

ACCOUNTS RECEIVABLE TURNOVER

                           3.50

times

                           4.29

times

DAYS' SALES IN RECEIVABLES

                       102.88

days

                         83.97

days

INVENTORY TURNOVER

                           5.15

times

                           4.63

times

ACCOUNTS PAYABLE PERIOD

                         72.13

days

                         69.71

days

RETURN ON ASSETS

                           1.23

times

                           1.31

times

SALES TURNOVER ON NET EQUIY

                           4.08

times

                           5.12

times

NET WORTH TIE-UP

                           1.35

 

                           1.50

 

ENDEBTEDNESS

                           2.31

 

                           2.90

 

EQUITY RATIO

                         30.21

%

                         25.63

%

WORKING CAPITAL RATIO

                         43.43

%

                         43.73

%

GENERAL SOLVENCY

                           1.43

 

                           1.34

 

RETURN ON NET EQUITY

                           8.13

%

                         17.30

%

RETURN ON SALES (PROFIT MARGIN)

                           1.99

%

                           3.38

%

GROSS PROFIT MARGIN

                         39.43

%

                         36.46

%

OPERATIONAL RESULT

                           1.96

%

                           3.94

%

SALES TURNOVER ON LIABILITIES

                           3.04

times

                           3.14

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

                               -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

                               -  

%

 

PRATI, DONADUZZI & CIA LTDA.

 

 

BALANCE SHEET ANALYSIS

 

 

 

31-12-05

 

ASSETS

 

%

Current Assets

 $        39,080,970

68.32

Fixed Assets

 $        17,372,828

30.37

TOTAL ASSETS

 $        57,199,190

100.00

LIABILITIES

 

 

Current Liabilities

 $        17,872,902

31.25

Long-Term Liabilities

 $        21,432,456

37.47

TOTAL LIABILITIES

 $        39,305,358

68.72

Deferred Income

 $                        -  

0.00

Net Equity

 $        17,893,832

31.28

TOTAL LIABILITIES + NET EQUITY

 $        57,199,190

100.00

PROFIT AND LOSS ACCOUNTS

 

 

Net Sales

 $        79,701,976

100.00

Costs

 $        46,996,114

58.96

Gross Profit

 $        32,705,863

41.04

Operating expenses

 $      (18,830,307)

-23.63

operational Result

 $        10,643,215

13.35

Net Profit (loss)

 $          7,067,108

8.87

COMPLEMENTARY DATA

 

 

Inventory

 $          9,810,024

 

Accounts receivable

 $        22,228,515

 

Accounts Payable

 $          8,991,262

 

Property, plant and equipment

 $        17,368,178

 

Purchases

 $        17,372,828

 

Financial Expenses

 $         (3,232,340)

 

Foreign Currency Assets

 

 

Foreign Currency Liabilities

 

 

Working Capital

 $        21,208,068

 

RATIOS:

 

 

QUICK RATIO

                       1.64

 

CURRENT RATIO

                       2.19

 

ACCOUNTS RECEIVABLE TURNOVER

                       3.59

times

DAYS' SALES IN RECEIVABLES

                   100.40

days

INVENTORY TURNOVER

                       4.79

times

ACCOUNTS PAYABLE PERIOD

                     68.87

days

RETURN ON ASSETS

                       1.39

times

SALES TURNOVER ON NET EQUIY

                       4.45

times

NET WORTH TIE-UP

                       0.97

 

ENDEBTEDNESS

                       2.20

 

EQUITY RATIO

                     31.28

%

WORKING CAPITAL RATIO

                   118.66

%

GENERAL SOLVENCY

                       1.46

 

RETURN ON NET EQUITY

                     39.49

%

RETURN ON SALES (PROFIT MARGIN)

                       8.87

%

GROSS PROFIT MARGIN

                     41.04

%

OPERATIONAL RESULT

                     13.35

%

SALES TURNOVER ON LIABILITIES

                       4.46

times

FOREIGN CURRENCY ON ASSETS

                           -  

%

FOREIGN CURRENCY ON LIABILITIES

                           -  

%

 

                                          

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.47.08

UK Pound

1

Rs.71.17

Euro

1

Rs.66.98

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions